Difference between revisions of "Team:Edinburgh OG/Human Practices"

Line 10: Line 10:
 
                     <h3> Summary <h3>
 
                     <h3> Summary <h3>
 
                     <p class="text-faded" style="font-size: 18px">Our project encompasses the characterisation of standardized biological parts that could potentially allow non-model microorganisms to be used as novel chassis. Domestication of non-model strains with high potential for industrial applications, could accelerate their understanding and increase the list of strains that are suitable for bioproduction. However, the domestication of strains of non-model organisms raises both biosafety and biosecurity challenges (e.g. unknown pathogenicity and toxicity), which are enhanced by the fast development of SynBIo and DIYBio fields. Such issues, if are not properly addressed, can be a risk for both users and their surroundings. In order to contribute to current risk assessment procedures, and as a precautionary step for both experienced and non-experienced users, the Edinburgh OG team worked on an accessible, easy-to-use program to evaluate the toxicity of curated secondary metabolites of both model and non-model organisms.</p>
 
                     <p class="text-faded" style="font-size: 18px">Our project encompasses the characterisation of standardized biological parts that could potentially allow non-model microorganisms to be used as novel chassis. Domestication of non-model strains with high potential for industrial applications, could accelerate their understanding and increase the list of strains that are suitable for bioproduction. However, the domestication of strains of non-model organisms raises both biosafety and biosecurity challenges (e.g. unknown pathogenicity and toxicity), which are enhanced by the fast development of SynBIo and DIYBio fields. Such issues, if are not properly addressed, can be a risk for both users and their surroundings. In order to contribute to current risk assessment procedures, and as a precautionary step for both experienced and non-experienced users, the Edinburgh OG team worked on an accessible, easy-to-use program to evaluate the toxicity of curated secondary metabolites of both model and non-model organisms.</p>
−
                  </div>
+
                    <a href="https://2016.igem.org/Team:Edinburgh_OG/HP/Silver" class="page-scroll btn btn-default btn-xl sr-button">Silver</a>
 +
                    <a href="https://2016.igem.org/Team:Edinburgh_OG/HP/Gold" class="page-scroll btn btn-default btn-xl sr-button">Gold</a>
 +
                      <a href="https://2016.igem.org/Team:Edinburgh_OG/Integrated_Practices" class="page-scroll btn btn-default btn-xl sr-button">Silver</a>
 +
 
 +
                      </div>
 
               </div>
 
               </div>
 
         </div>
 
         </div>
 
     </section>   
 
     </section>   
−
<!-- ________________________________________Silver______________________________________-->                
+
<!-- ________________________________________Silver______________________________________--                 
 
<section id="HP_Silver">
 
<section id="HP_Silver">
 
   <div class="container" style="background-color:white">
 
   <div class="container" style="background-color:white">
Line 51: Line 55:
 
     </div>
 
     </div>
 
</section>
 
</section>
−
<!-- ________________________________________Gold______________________________________-->               
+
<!-- ________________________________________Gold______________________________________--            
 
<section id="HP_Gold">
 
<section id="HP_Gold">
 
   <div class="container" style="background-color:#f9ffa5">
 
   <div class="container" style="background-color:#f9ffa5">

Revision as of 00:16, 20 October 2016

-->

Human Practices

Summary

Our project encompasses the characterisation of standardized biological parts that could potentially allow non-model microorganisms to be used as novel chassis. Domestication of non-model strains with high potential for industrial applications, could accelerate their understanding and increase the list of strains that are suitable for bioproduction. However, the domestication of strains of non-model organisms raises both biosafety and biosecurity challenges (e.g. unknown pathogenicity and toxicity), which are enhanced by the fast development of SynBIo and DIYBio fields. Such issues, if are not properly addressed, can be a risk for both users and their surroundings. In order to contribute to current risk assessment procedures, and as a precautionary step for both experienced and non-experienced users, the Edinburgh OG team worked on an accessible, easy-to-use program to evaluate the toxicity of curated secondary metabolites of both model and non-model organisms.

Silver Gold Silver